Global Cosmetic Surgery and Procedure Market | Inkwood Research

COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2019-2027

• The global cosmetic surgery and procedure market is expected to generate a net worth of $xx million in 2018. • The market is anticipated to rise at a CAGR of 5.76% between the forecast years of 2019-2027, generating a net worth of $48,692 million by the end of 2027.

• The important drivers increasing growth in the global cosmetic surgery and procedure market are a rise in aging population and rapid growth of the aesthetic industry. • Rise in aging population results in improved demand for antiaging cosmetic and procedures. • The high rate of aesthetic usages and difficulties related to cosmetic treatment are the major factors hindering the cosmetic surgery and procedure market. • The demand for cosmetic surgeries and procedures is rapidly increasing worldwide.

“The global cosmetic surgery and procedure market are anticipated to grow to $48,692 million by 2027, at a CAGR of 5.76% between 2019 and 2027.�

The North America market is anticipated to expand further with a CAGR of 5.79% over the estimated period of 2019-2027.

The Europe cosmetic surgery and procedures market collected a revenue of $XX million in 2018. The market is expected to rise with the second highest CAGR of 5.78% over the forecast period of 2019-2027.

The Asia-Pacific cosmetic surgery and procedures market represents the fastest growing region for the global market, with a CAGR growth of 6.05% over the forecast years of 2019-2027.

Lumenis, Merz Pharma, Depuy Synthes Companies, Cutera, Syneron Medical, Sientra Inc., Sinclair Pharma, Nestle, Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), Cynosure, Inc., Galderma, Alma Lasers Inc., IPSEN, Allergan PLC and Johnson & Johnson are the eminent market players operating in the global market.